Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China

Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China

Macrolides such as erythromycin are the empirical treatment of Bordetella pertussis infections. China has experienced an increase in erythromycin-resistant B. pertussis isolates since they were first reported in 2013. Here, we undertook a genomic study on Chinese B. pertussis isolates from 2012 to 2...

Full description

Saved in:
Bibliographic Details
Main Authors: Zheng Xu, Zengguo Wang, Yang Luan, Yarong Li, Xiaoguai Liu, Xiaokang Peng, Sophie Octavia, Michael Payne, Ruiting Lan
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Emerging Microbes and Infections
Subjects:
Bordetella pertussis
erythromycin-resistant
genomic epidemiology
fhaB
ptxP1
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2019.1587315
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items